Hemophilia B
Despite CSL’s hemophilia B gene therapy, NICE is not persuaded
SG Tylor
The UK’s National Institute for Health and Care Excellence (NICE) has expressed hesitation in recommending approval for CSL Behring and ...
FDA Accepts Pfizerās Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
SG Tylor
Source – Pfizer On 28 June 2023, Pfizer announced that the US Food and Drug Administration (FDA) and the European ...